Emergency Contraceptive Pills Market

Market Overview:

The global emergency contraceptive pills market size reached US$ 585.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 814.3 Million by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.

Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.

Emergency Contraceptive Pills Market Trends:

The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global emergency contraceptive pills market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type and distribution channel.

Type Insights:

• Combination Pills
• Progesterone Pills
• Others
   

The report has provided a detailed breakup and analysis of the emergency contraceptive pills market based on the type. This includes combination pills, progesterone pills, and others. According to the report, combination pills represented the largest segment.

Distribution Channel Insights:

• Retail Stores
• Online Stores
• Others
   

A detailed breakup and analysis of the emergency contraceptive pills market based on the distribution channel has also been provided in the report. This includes retail stores, online stores, and others. According to the report, retail stores accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women’s health, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Questions Answered in This Report:

• How has the global emergency contraceptive pills market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global emergency contraceptive pills market?
• What is the impact of each driver, restraint, and opportunity on the global emergency contraceptive pills market?
• What are the key regional markets?
• Which countries represent the most attractive emergency contraceptive pills market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the emergency contraceptive pills market?
• What is the breakup of the market based on the distribution channel?
• Which is the most attractive distribution channel in the emergency contraceptive pills market?
• What is the competitive structure of the global emergency contraceptive pills market?
• Who are the key players/companies in the global emergency contraceptive pills market?

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the emergency contraceptive pills market from 2018-2032.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global emergency contraceptive pills market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the emergency contraceptive pills industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.